NCT00697450View on ClinicalTrials.gov

Observational Study on the Weight Effect of Insulin Detemir (Levemir®) in Type 2 Diabetics

CompletedOBSERVATIONAL
Enrollment

206

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
DiabetesDiabetes Mellitus, Type 2
Interventions
DRUG

insulin detemir

Start dose, frequency of dosing, dose titration to be prescribed by the physician as a result of a normal clinical evaluation

Trial Locations (1)

16000

Novo Nordisk Investigational Site, Prague

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY

NCT00697450 - Observational Study on the Weight Effect of Insulin Detemir (Levemir®) in Type 2 Diabetics | Biotech Hunter | Biotech Hunter